Azithromycin for treating uncomplicated malaria

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Van Eijk, Anna ^a   Terlouw, D J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AZITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; LINCOSAMIDE; MACROLIDE; QUININE; TETRACYCLINE;

CLINICAL ASSESSMENT; CLINICAL PROTOCOL; DRUG HALF LIFE; DRUG INDICATION; FOLLOW UP; HUMAN; MALARIA; MORBIDITY; MORTALITY; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM OVALE; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; REVIEW; TREATMENT DURATION; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT;

EID: 44949173198     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006688     Document Type: Review

References (28)

1. Adair 1998 Adair CD, Gunter M, Stovall TG, McElroy G, Veille JC, Ernest JM. Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin. Obstetrics and Gynecology 1998;91(2):165-8.
2. Andersen 1995 Andersen SL, Ager A, McGreevy P, Schuster BG, Wesche D, Kuschner R, et al.Activity of azithromycin as a blood schizonticide against rodent and human plasmodium in vivo. American Journal of Tropical Medicine and Hygiene 1995;52(2):159-61.
3. Biswas 2001 Biswas S. In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum. Journal of Postgraduate Medicine 2001;47(4):240-3.
4. Bloland 2003 Bloland PB, Ringwald P, Snow RW. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparium malaria [WHO/HTM/RBM/2003.50]. Geneva: World Health Organization, 2003.
5. Dunne 2005a Dunne MW, Singh N, Shukla M, Valecha N, Bhattacharyya PC, Dev V, et al.A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodiumfalciparummalaria in India. Journal of Infectious Diseases 2005;191(10):1582-8.
6. Dunne 2005b Dunne MW, Singh N, Shukla M, Valecha N, Bhattacharyya PC, Patel K, et al.A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India. American Journal of Tropical Medicine and Hygiene 2005;73(6):1108-11.
7. Gingras 1992 Gingras BA, Jensen JB. Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine resistant strains of Plasmodium falciparum in vitro. American Journal of Tropical Medicine and Hygiene 1992;47(3):378-82.
8. Gingras 1993 Gingras BA, Jensen JB. Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. American Journal of Tropical Medicine and Hygiene 1993;49(1):101-5.
9. Gray 2001 Gray RH, Wabwire-Mangen F, Kigozi G, Sewankambo NK, Serwadda D, Moulton LH, et al.Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. American Journal of Obstetrics and Gynecology 2001;185(5):1209-17.
10. Higgins 2006 Higgins JPT, Green S, editors. Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Appendix 5b. www.cochrane.org/resources/handbook/ hbook.htm (accessed 1 March 2007).
11. Juni 2001 Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6.
12. Krudsood 2000 Krudsood S, Silachamroon U, Wilairatana P, Singhasivanon P, Phumratanaprapin W, Chalermrut K, et al.A randomized clinical trial of combinations of artesunate and azithromycin for treatment of uncomplicated Plasmodium falciparum malaria in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 2000;31(4):801-7.
13. Krudsood 2002 Krudsood S, Buchachart K, Chalermut K, Charusabha C, Treepasertsuk S, Haoharn O, et al.A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health 2002;33(3):525-31.
14. Miller 2006 Miller RS, Wongsrichanalai C, Buathong N, McDaniel P, Walsh DS, Knirsch C, et al.Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose ranging study. American Journal of Tropical Medicine and Hygiene 2006;74(3):401-6.
15. Na-Bangchang 1996 Na-Bangchang K, Kanda T, Tipawangso P, Thanavibul A, Suprakob K, Ibrahim M, et al.Activity of artemether-azithromycin versus artemether-doxycycline in the treatment of multiple drug resistant falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health 1996;27(3):522-5.
16. Neerja 2004 Neerja J, Puri SK. Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swissmice. Experimental Parasitology 2004;107(3-4):120-4.
17. Noedl 2001 Noedl H, Wernsdorfer WH, Krudsood S, Wilairatana P, Kollaritsch H, Wiedermann G, et al.Antimalarial activity of azithromycin, artemisinin and dihydroartemisinin in fresh isolates of Plasmodium falciparum in Thailand. Acta Tropica 2001;80(1):39-44.
18. Nosten 2006 Nosten F, McGready R, d'Alessandro U, Bonell A, Verhoeff F, Menendez C, et al.Antimalarial drugs in pregnancy: a review. Current Drug Safety 2006;1(1):1-15.
19. Ogasawara 1999 Ogasawara KK, Goodwin TM. Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery. Journal of Maternal-Fetal Medicine 1999;8(1):12-6.
20. Ohrt 2002 Ohrt C, Willingmyre GD, Lee P, Knirsch C, Milhous W. Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. Antimicrobial Agents and Chemotherapy 2002;46(8):2518-24.
21. Pradines 2001 Pradines B, Rogier C, Fusai T, Mosnier J, Daries W, Barret E, et al.In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron. Antimicrobial Agents and Chemotherapy 2001;45(6):1746-50.
22. Puri 2000 Puri SK, Singh N. Azithromycin: antimalarial profile against blood-and sporozoite-induced infections in mice andmonkeys. Experimental Parasitology 2000;94(1):8-14.
23. RBM/UNICEF 2005 Global Partnership to Roll Back Malaria, UNICEF. World malaria report: 2005. Geneva: World Health Organization, 2005.
24. Review Manager 4.2 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
25. Starr 1998 Starr M. Malaria affects children and pregnant women most. BMJ 2000;321(7271):1288.
26. WHO/AFRO 2001 World Health Organization/AFRO. Severe malaria in the African region: results of a multicentre study. Liaison Bulletin of the Malaria Programme WHO/AFRO 2001; Vol. 4, issue 2:1-3.
27. WHO/RBM 2006 World Health Organization, Roll Back Malaria Department. Guidelines for the treatment of malaria [WHO/HTM/MAL/2006.1108]. Geneva: World Health Organization, 2006.
28. Yeo 1995 Yeo AE, Rieckmann KH. Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro. International Journal for Parasitology 1995;25(4):531-2.